Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 18060
Country/Region: Tanzania
Year: 2017
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $8,572,436 Additional Pipeline Funding: $8,000,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $163,864
Care: TB/HIV (HVTB) $728,591
Care: Pediatric Care and Support (PDCS) $169,463
Laboratory Infrastructure (HLAB) $120,000
Testing: HIV Testing and Counseling (HVCT) $1,112,255
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,778,704
Treatment: Adult Treatment (HTXS) $3,378,802
Treatment: Pediatric Treatment (PDTX) $1,120,757
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2018 10
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 10
GEND_GBV 25-49, Male, Sexual Violence (Post-Rape Care) 2018 40
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2018 1
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 456
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 7,466
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 3,196
GEND_GBV Number of people receiving post-GBV care 2018 11,124
GEND_GBV Unknown Age, Female, Physical and/or Emotional Violence 2018 19
GEND_GBV Unknown Age, Male, Physical and/or Emotional Violence 2018 9
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 1,184,914
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 1,692
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 8,264
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 13,698
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 15,240
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 27,653
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 20,374
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 220,602
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 20,507
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 23,204
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 5,377
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 4,030
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 29,523
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 34,685
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 408,970
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 297,686
HTS_TST Sum of Test Result disaggregates 2018 46,908
HTS_TST_POS By Test Result: Positive 2018 46,908
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 95
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 121
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 150
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 4,663
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 3,539
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 3,976
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 145
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 195
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 300
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 229
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 310
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 424
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 18,671
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 13,984
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,995
PMTCT_ART New on ART 2018 3,461
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 6,456
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 228,560
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 6,435
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,253
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 5,053
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 102
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 27
PMTCT_STAT By Age (Numerator): 25-49 2018 1,469
PMTCT_STAT By Age (Numerator): Unknown Age 2018 226,034
PMTCT_STAT By Number of known positives: 25-49 2018 15
PMTCT_STAT By Number of known positives: Unknown Age 2018 2,831
PMTCT_STAT By Number of new negative: 25-49 2018 1,432
PMTCT_STAT By Number of new negative: Unknown Age 2018 220,234
PMTCT_STAT By Number of new positives: 25-49 2018 22
PMTCT_STAT By Number of new positives: Unknown Age 2018 3,977
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 228,560
PMTCT_STAT_den By Age (Denominator): 25-49 2018 1,546
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 242,127
TB_PREV By Age/Sex (Numerator): <15, Female 2018 524
TB_PREV By Age/Sex (Numerator): <15, Male 2018 804
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 5,036
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 7,481
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 13,871
TB_PREV By Therapy type (Numerator): Continuous IPT 2018 4
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 13,875
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 27,740
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 1,095
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 1,649
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 10,006
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 14,970
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 27,738
TB_PREV_den By Therapy type (Denominator): Continuous IPT 2018 2
TX_CURR Age/Sex: <1 2018 50
TX_CURR Age/Sex: <1-9 2018 387
TX_CURR Age/Sex: 10-14 Female 2018 83
TX_CURR Age/Sex: 10-14 Male 2018 68
TX_CURR Age/Sex: 15-19 Female 2018 189
TX_CURR Age/Sex: 15-19 Male 2018 63
TX_CURR Age/Sex: 20-24 Female 2018 500
TX_CURR Age/Sex: 20-24 Male 2018 63
TX_CURR Age/Sex: 25-49 Female 2018 4,374
TX_CURR Age/Sex: 25-49 Male 2018 2,010
TX_CURR Age/Sex: 50+ Female 2018 726
TX_CURR Age/Sex: 50+ Male 2018 517
TX_CURR Aggregated Age/Sex: <15 Female 2018 5,338
TX_CURR Aggregated Age/Sex: <15 Male 2018 5,137
TX_CURR Aggregated Age/Sex: 15+ Female 2018 94,557
TX_CURR Aggregated Age/Sex: 15+ Male 2018 39,570
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 153,642
TX_CURR Sum of age/sex disaggregates 2018 252
TX_CURR Sum of Aggregated Age/Sex <15 2018 10,475
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 134,127
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 144,602
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 1,170
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 966
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 31,903
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 13,664
TX_NEW Breastfeeding status 2018 926
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 47,703
TX_NEW Pregnancy status 2018 3,406
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 47,703
TX_PVLS <15, Routine, Unknown Sex 2018 24
TX_PVLS <15, Routine, Unknown Sex 2018 1
TX_PVLS <15, Targeted, Unknown Sex 2018 3
TX_PVLS 15+, Routine, Unknown Sex 2018 420
TX_PVLS 15+, Routine, Unknown Sex 2018 22
TX_PVLS 15+, Targeted, Unknown Sex 2018 44
TX_PVLS 15+, Targeted, Unknown Sex 2018 2
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 115,102
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 103,589
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,424
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 375
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 3,272
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 353
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 60,932
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 6,787
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 25,095
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 2,808
TX_PVLS Numerator: Indication: Routine 2018 93,240
TX_PVLS Numerator: Indication: Targeted 2018 10,349
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 365
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 59
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 3,024
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 737
TX_PVLS Pregnant, Undocumented Test Indication 2018 1
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,783
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 397
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 3,655
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 388
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 67,977
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 7,556
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 28,070
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 3,126
TX_PVLS_den Denominator: Indication: Routine 2018 103,482
TX_PVLS_den Denominator: Indication: Targeted 2018 11,485
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 416
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 75
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 3,480
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 870
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,607
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 917
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 15,694
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,681
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 24,980
TX_RET Numerator by Status: Breastfeeding 2018 2,409
TX_RET Numerator by Status: Pregnant 2018 456
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 29,375
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,895
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,076
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 18,467
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 7,860
TX_RET_den Denominator by Status: Breastfeeding 2018 2,843
TX_RET_den Denominator by Status: Pregnant 2018 545
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 145,969
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 3,646
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 111
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 181
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 1,332
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 1,974
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 5,866
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 8,753
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 52,468
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 78,687
TX_TB_den Denominator: By Screen Result: Negative 2018 141,800
TX_TB_den Denominator: By Screen Result: Positive 2018 3,624
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 8
Cross Cutting Budget Categories and Known Amounts Total: $3,426,704
Gender: Gender Based Violence (GBV) $1,760,752
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $1,565,952
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Promoting gender-related policies and laws that increase legal protection
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Water $100,000